Table 2

Trends in proportion of costs for antineoplastic agents for eye cancer in Taiwan by drug class

Cost (US$)
2009201020112012
Drug classDrug namesCost(%)Cost(%)Cost(%)Cost(%)
All antineoplastic agents60 968100.0095 335100.0075 006100.0099 455100.00
Targeted therapies921815.1233 92735.5920 73227.6458 55958.88
 Monoclonal antibodiesRituximab921815.1295069.9750346.7173727.41
 Protein kinase inhibitorsGefitinib, erlotinib, sunitinib00.0024 42225.6215 67220.8945 03445.28
 Other targeted therapiesBortezomib00.0000.00260.0361526.19
Alkylating agents15 79125.9017 23218.0817 17422.9022 48222.61
 Nitrogen mustard analoguesCyclophosphamide, chlorambucil, melphalan, ifosfamide776312.7311 34311.90872711.6385808.63
 NitrosoureasCarmustine00.0000.003600.4800.00
 Other alkylating agentsTemozolomide, dacarbazine802813.1758896.18808710.7813 90213.98
Antimetabolites43247.0917 52218.3816 39921.8693959.45
 Folic acid analoguesMethotrexate, pemetrexed,1600.2671097.4612 07016.0936843.70
 Pyrimidine analoguesCytarabine, fluorouracil, tegafur (=ftorafur), gemcitabine, tegafur+uracil41646.8310 41310.9243295.7757125.74
Plant alkaloids and other natural products16 30226.7410 78411.3170929.4520522.06
 Vinca alkaloids and analoguesVinblastine, vincristine, vinorelbine10521.7360136.316140.829690.97
 Podophyllotoxin derivativesEtoposide787312.9147715.0023893.1910831.09
 TaxanesPaclitaxel, docetaxel737812.1000.0040895.4500.00
Cytotoxic antibiotics and related substances987616.2010 93811.47759010.1232023.22
 ActinomycinesDactinomycin,440.0700.0000.0000.00
 Anthracyclines and related substancesDoxorubicin, epirubicin, idarubicin849513.9391989.6570949.4623832.40
 Other cytotoxic antibioticsBleomycin, mitomycin C13382.1917401.824960.668180.82
Other agents54568.9549325.1760208.0337653.79
 Platinum compoundsCisplatin, carboplatin54568.9549325.1760208.0337653.79